fluorouracil has been researched along with Dysplastic Nevus Syndrome, Hereditary in 4 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examined the effects of folate environment of oligochitosan nanoparticles on their cellular internalization profiles in human melanoma cells." | 7.96 | Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma. ( Kumar, P; Musalli, AH; Roy, P; Talukdar, PD; Wong, TW, 2020) |
| "Metastatic skin lesions of gastric cancers usually appear as nonspecific, firm, and hyperpigmented nodules." | 5.51 | Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug. ( Covarelli, P; De Giorgi, V; Gori, A; Maida, P; Scarfì, F; Silvestri, F; Trane, L, 2019) |
| "This study examined the effects of folate environment of oligochitosan nanoparticles on their cellular internalization profiles in human melanoma cells." | 3.96 | Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma. ( Kumar, P; Musalli, AH; Roy, P; Talukdar, PD; Wong, TW, 2020) |
| "Metastatic skin lesions of gastric cancers usually appear as nonspecific, firm, and hyperpigmented nodules." | 1.51 | Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug. ( Covarelli, P; De Giorgi, V; Gori, A; Maida, P; Scarfì, F; Silvestri, F; Trane, L, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A | 1 |
| Madni, A | 1 |
| Shah, H | 1 |
| Jamshaid, T | 1 |
| Jan, N | 1 |
| Khan, S | 1 |
| Khan, MM | 1 |
| Mahmood, MA | 1 |
| Carmona-Sarabia, L | 1 |
| Quiñones Vélez, G | 1 |
| Escalera-Joy, AM | 1 |
| Mojica-Vázquez, D | 1 |
| Esteves-Vega, S | 1 |
| Peterson-Peguero, EA | 1 |
| López-Mejías, V | 1 |
| De Giorgi, V | 1 |
| Scarfì, F | 1 |
| Trane, L | 1 |
| Silvestri, F | 1 |
| Maida, P | 1 |
| Gori, A | 1 |
| Covarelli, P | 1 |
| Musalli, AH | 1 |
| Talukdar, PD | 1 |
| Roy, P | 1 |
| Kumar, P | 1 |
| Wong, TW | 1 |
4 other studies available for fluorouracil and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Delayed-Action Preparations; Fluorouracil; | 2023 |
Design of Extended Bisphosphonate-Based Coordination Polymers as Bone-Targeted Drug Delivery Systems for Breast Cancer-Induced Osteolytic Metastasis and Other Bone Therapies.
Topics: Benzene; Bone and Bones; Breast Neoplasms; Diphosphonates; Drug Delivery Systems; Female; Fluorourac | 2023 |
Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2019 |
Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitin; Chitosan; Drug Carriers; Fluorouracil; Folic Acid; | 2020 |